1. Home
  2. HYFM vs MBIO Comparison

HYFM vs MBIO Comparison

Compare HYFM & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$0.78

Market Cap

4.5M

Sector

Industrials

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$0.38

Market Cap

4.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFM
MBIO
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5M
4.1M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
HYFM
MBIO
Price
$0.78
$0.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 54.9K
38.8K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 98.99
EPS
N/A
★ N/A
Revenue
★ $134,252,000.00
N/A
Revenue This Year
$54.93
N/A
Revenue Next Year
$5.31
$405.45
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.50
$0.37
52 Week High
$3.20
$1.69

Technical Indicators

Market Signals
Indicator
HYFM
MBIO
Relative Strength Index (RSI) 38.94 26.21
Support Level $0.50 N/A
Resistance Level $1.04 $0.56
Average True Range (ATR) 0.10 0.03
MACD -0.02 -0.01
Stochastic Oscillator 18.78 3.22

Price Performance

Historical Comparison
HYFM
MBIO

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: